# In Vivo Target Gene Activation via CRISPR/Cas9-Mediated Trans-epigenetic Modulation

Article · Hsin‐Kai Liao, Fumiyuki Hatanaka, Toshikazu Araoka, Pradeep Reddy, Min-Zu Wu, Yinghui Sui, Takayoshi Yamauchi, Masahiro Sakurai, David D. O’Keefe, Estrella Núñez‐Delicado, Pedro Guillén, Josep Maria Campistol, Cheng-Jang Wu, Li‐Fan Lu, Concepción Rodrı́guez Esteban, Juan Carlos Izpisúa Belmonte

- Archive id: doi:10.1016/j.cell.2017.10.025
- Published: 2017-12-01
- Venue: Cell
- DOI: https://doi.org/10.1016/j.cell.2017.10.025
- PMID: 29224783
- Citations: 451
- Source URL: https://doi.org/10.1016/j.cell.2017.10.025
- PDF: http://www.cell.com/article/S0092867417312473/pdf
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [CRISPR & Gene-Editing Therapies](https://space-kitty.com/topics/gene-editing-therapies)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.
